Workflow
乳制品
icon
Search documents
君乐宝递交港交所上市申请,多元化渠道布局奠定增长基础
Sou Hu Cai Jing· 2026-01-31 09:15
市场空间广阔,国际化视野开启未来篇章 全国纵深布局,渠道渗透力奠定增长基础 广泛的覆盖并未耗尽君乐宝的增长潜力。从县级行政区渗透率看,依然存在可观的空白市场待开拓。在 国内市场纵深发展的同时,君乐宝已迈出国际化探索的步伐。悦鲜活等产品成功进入中国香港、中国澳 门市场,并以港澳地区作为桥头堡,为未来辐射东南亚乃至更广阔的海外市场积累了宝贵经验,奠定了 长远基础。 君乐宝的销售网络展现出出众的广度与深度。截至2025年9月30日,公司业务已覆盖中国内地全部31个 省级行政区,产品触达约2200个区县,实现对全国县级行政区约77%的覆盖。在高消费力的华东、华中 及华南市场,君乐宝液奶产品展现出强劲的增长动能,相关区域在2024年及2025年前九个月的收入增速 均保持在15%以上。为强化区域市场地位并挖掘增长潜力,君乐宝通过战略性收购持续完善版图。 对"银桥"与"来思尔"等区域知名品牌的整合,显著巩固了其在西北与西南市场的根基,体现了公司以全 国性品牌引领与区域性品牌深耕相结合的战略智慧。 此次赴港申请上市,无疑将为君乐宝注入新的发展动能。凭借已经构筑的全国性深度分销网络、稳固的 渠道伙伴关系以及清晰的区域与国际化拓 ...
君乐宝递交港股上市申请,盈利能力持续提升赋能高质量发展
Sou Hu Cai Jing· 2026-01-31 08:51
Core Insights - Junlebao Dairy Group has submitted its main board listing application to the Hong Kong Stock Exchange, marking a significant milestone in its 30-year journey as a leading comprehensive dairy enterprise in China [1] - The company has established itself as the third-largest comprehensive dairy company in China, demonstrating solid market positioning and showcasing its high-quality growth [1] Financial Performance - Junlebao's total revenue increased from RMB 17.546 billion in 2023 to RMB 19.833 billion in 2024, representing a year-on-year growth of 13.0% [3] - For the first three quarters of 2025, the revenue reached RMB 15.134 billion, indicating stable growth compared to the same period last year [3] - Adjusted net profit surged from RMB 600 million in 2023 to RMB 1.16 billion in 2024, with the first three quarters of 2025 showing an adjusted net profit of RMB 940 million, reflecting strong growth momentum [3] - The adjusted net profit margin improved significantly from 3.4% in 2023 to 5.9% in 2024, further increasing to 6.2% in the first nine months of 2025 [3] Strategic Focus and Operational Excellence - The systematic improvement in profitability is attributed to Junlebao's strategic focus on high-growth, high-value segments, particularly in low-temperature liquid milk and premium brands [4] - The company has optimized its product structure and overall gross margin by increasing the sales proportion of higher-margin fresh milk and low-temperature yogurt [4] - Junlebao's integrated supply chain model has demonstrated strong cost control and synergy benefits during periods of raw material fluctuations [4] - Continuous digital transformation efforts have enhanced operational efficiency across production, supply chain, and marketing [4] Market Position and Future Outlook - Despite challenges in the macroeconomic and consumer environment, Junlebao has achieved robust revenue expansion and nearly doubled its profitability, providing compelling value for its upcoming capital market journey [4] - The listing in Hong Kong is seen as a new starting point for Junlebao, with expectations to further consolidate its competitive advantage, accelerate innovation, and expand its global footprint [4]
君乐宝叩响港股上市大门,产能布局升级剑指全球市场
Sou Hu Cai Jing· 2026-01-31 08:51
Core Insights - Junlebao Dairy Group has submitted its application for a mainboard listing on the Hong Kong Stock Exchange, marking a significant milestone in its development [1] - The company has established itself as a leading player in the Chinese dairy industry, ranking third among comprehensive dairy enterprises by retail sales in 2024 according to Frost & Sullivan [1] Group 1: Business Model and Operations - Junlebao's core competitiveness lies in its integrated operation model covering the entire dairy supply chain, including farming, research, production, and distribution [3] - As of September 30, 2025, the company operates 33 modern owned farms and 20 dairy production facilities in China, with a dairy cow inventory of 192,000, ranking third nationally [3] - The self-sufficiency rate of Junlebao's milk source is projected to reach 66% in 2024, the highest among large comprehensive dairy enterprises in China [3] Group 2: Research and Innovation - Research and innovation are central to Junlebao's growth, with the establishment of a leading "Scientific Nutrition Research Institute" that collaborates with top research institutions [5] - The company has successfully developed several market-leading products, including the "Yuexianhuo" fresh milk brand, which holds the largest market share in China's high-end fresh milk segment [5] - Junlebao has expanded its product range to include high-quality cream and butter for the catering and baking markets, addressing consumer upgrade demands [5] Group 3: Quality Management and Industry Standards - Junlebao's quality management system spans the entire supply chain, ensuring product quality stability and traceability from farm to table [6] - The company actively participates in industry standard-setting, promoting high-quality development in the dairy sector [6] - Through continuous technological innovation and strict quality control, Junlebao has established itself as an industry benchmark in food safety and nutrition [6] Group 4: Future Development and Market Strategy - The upcoming listing in Hong Kong is expected to open a new chapter for Junlebao, allowing it to deepen its focus on the Chinese market while seizing international opportunities [6] - The company plans to increase R&D investment, enhance production capacity, and expand its sales network to provide higher quality and healthier dairy products globally [6] - Junlebao's development journey reflects the transition of the Chinese dairy industry from scale expansion to high-quality development, positioning itself for a more influential global presence [6]
君乐宝港股上市申请提交,迈出快速发展的关键一步
Sou Hu Cai Jing· 2026-01-31 08:51
2026年 1月19日,中国领先的综合乳制品企业君乐宝乳业集团股份有限公司正式向香港联交所递交主板 上市申请。这家深耕乳制品行业三十年的头部企业,凭借全产业链一体化运营模式与强大品牌矩阵,在 高增长赛道精准布局,稳居市场前列。据弗若斯特沙利文报告,按 2024 年中国市场零售额统计,君乐 宝在中国综合性乳制品企业中排名第三。此次递表港交所,标志着其资本战略迈入全新阶段,而在上市 进程中,君乐宝就管理团队常驻地安排获得联交所豁免,更以高效沟通体系筑牢治理根基,彰显合规发 展的坚定决心。 作为从区域性乳品厂逐步成长起来的行业佼佼者,君乐宝多年来始终深耕乳制品领域,构建起了坚实的 发展基础。在产业布局方面,君乐宝已在华北、华东、华中、华南、西南、西北、东北等全国多个区域 建成乳制品研发生产基地与奶牛养殖牧场,形成覆盖广泛的产业网络。 在夯实产业基础的同时,君乐宝也在不断通过战略升级与技术创新驱动企业发展。2023年2月,君乐宝 正式启动科学战略,将前沿科学技术与乳业全产业链进行深度融合。这一战略并非停留在概念层面,而 是切实赋能到奶牛养殖、乳品生产、乳品研发、品质升级等全产业链各个环节。通过科学战略的推进, 君乐宝 ...
君乐宝上市申请已递交,国内乳品领军企业迈入资本市场
Sou Hu Cai Jing· 2026-01-31 08:45
作为从区域性乳品厂逐步成长起来的行业佼佼者,君乐宝多年来始终深耕乳制品领域,构建起了坚实的 发展基础。在产业布局方面,君乐宝已在华北、华东、华中、华南、西南、西北、东北等全国多个区域 建成乳制品研发生产基地与奶牛养殖牧场,形成覆盖广泛的产业网络。 产品矩阵更是丰富多元,涵盖低温液奶、奶粉、常温液奶、其他乳制品等多个品类,能够满足不同消费 场景下消费者的需求。第三方数据显示,君乐宝旗下的简醇酸奶是低温酸奶第一品牌,2024年悦鲜活强 势登顶中国高端鲜奶市场份额第一,市占率高达24.0%。此外,君乐宝还是本土前三大婴幼儿配方奶粉 生产商,君乐宝奶牛存栏量在业内位居前列。 在夯实产业基础的同时,君乐宝也在不断通过战略升级与技术创新驱动企业发展。2023年2月,君乐宝 正式启动科学战略,将前沿科学技术与乳业全产业链进行深度融合。这一战略并非停留在概念层面,而 是切实赋能到奶牛养殖、乳品生产、乳品研发、品质升级等全产业链各个环节。通过科学战略的推进, 君乐宝致力于打造科学产品矩阵,为全年龄段人群提供健康升级解决方案。 对于君乐宝而言,启动IPO进程有着重要的战略意义。通过对接资本市场,君乐宝有望进一步规范企业 运作,提 ...
“驼乳粉”广告涉虚假宣传,那拉尊驼乳业被罚45万元
Bei Jing Shang Bao· 2026-01-31 07:29
Core Viewpoint - The National Market Supervision Administration of China has penalized Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. for publishing false advertising related to health claims and misleading content in their product promotions [1] Group 1: Company Actions - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. was fined 450,000 yuan for including false claims in their advertisements, such as references to disease prevention and treatment [1] - The company’s advertisement for "camel milk powder" included misleading statements about being part of the "Belt and Road Initiative" and offered "discount sales quotas" in relevant provinces [1] Group 2: Regulatory Response - The fine was imposed by the Haizhu District Market Supervision Bureau in Guangzhou, based on violations of the Advertising Law of the People's Republic of China [1] - The regulatory body found that the company failed to use citation content accurately and truthfully in their advertisements [1]
大爆发!“组团”来了:君乐宝、钱大妈、袁记食品......知名消费企业掀港股上市潮
Zhong Guo Ji Jin Bao· 2026-01-31 06:58
Core Viewpoint - The Hong Kong capital market is experiencing a surge in listings from consumer companies, with notable firms like Junlebao, Qian Dama, and Yuanji Food preparing to go public, indicating a strategic move amidst a challenging domestic consumption environment [1][5]. Group 1: Market Trends - In early 2026, 14 consumer companies have disclosed H-share prospectuses, a significant increase compared to the same period in 2025 [1]. - The IPO of Dongpeng Beverage, expected to raise HKD 10 billion, marks the largest IPO in the Asian beverage sector in recent years [1]. - The trend of consumer companies going public in Hong Kong reflects a strategic response to various market conditions, including policy support and capital market changes [5][6]. Group 2: Company Highlights - Junlebao, a leading player in the dairy industry, aims to raise funds for factory construction, capacity expansion, brand marketing, and digital transformation, with annual revenue around RMB 20 billion [2]. - Jin Xing Beer, a traditional brewery, has shown explosive growth, with revenue increasing from RMB 356 million to RMB 1.109 billion and net profit soaring from RMB 12 million to RMB 305 million over two years [3]. - The emerging beauty brand Banmu Huatian is also pursuing a Hong Kong listing to enhance R&D and brand development in a competitive market [3]. Group 3: Factors Driving Listings - Policy support from the Chinese government has facilitated the process for consumer companies to list in Hong Kong, with measures introduced to encourage leading firms to access capital markets [5][6]. - The shift towards Hong Kong listings is also driven by tightening A-share market conditions for consumer companies, making Hong Kong a more attractive option for capital raising [6]. - The influx of venture capital and private equity into emerging consumer firms has created pressure for exits, making public listings a viable path for capital recovery [7]. Group 4: Market Performance and Challenges - There is a noticeable divergence in stock performance among consumer companies listed in Hong Kong, with some achieving high valuations while others struggle post-IPO [8][9]. - The market favors companies with strong brand presence and visible cash flow, while smaller brands face liquidity discounts due to lack of profitability [9]. - Successful expansion in the consumer sector requires matching growth with profitability, as merely increasing store numbers is no longer sufficient to attract capital [9].
蒙牛“亮剑”,“奶酪女王”为何在资本博弈中出局?
Xin Lang Cai Jing· 2026-01-31 03:35
Core Viewpoint - The founder of Miaokelan Duo, Chai Xiu, has been removed from her positions as Vice Chairman, General Manager, and Legal Representative, marking the end of her era in the company [3][27]. Group 1: Management Changes - Chai Xiu's removal was announced on January 25, with the company stating that she would retain her position as a board member only [3][27]. - The new appointee, Kuai Yulong, is a seasoned executive from Mengniu Dairy, indicating a shift towards a more corporate management style [5][29]. - Following Chai's dismissal, Mengniu Dairy increased its stake in Miaokelan Duo to 37.04% [41]. Group 2: Financial and Legal Issues - The immediate cause of Chai's removal was a long-standing investment dispute involving a fund she helped establish, which has resulted in significant financial losses for the company [9][33]. - Miaokelan Duo has initiated arbitration against Chai for failing to fulfill a compensation commitment related to this investment, which is expected to impact the company's net profit by approximately 119 to 127 million yuan in 2025 [4][11][35]. - The company’s financial performance has been declining, with revenue growth slowing since 2021 and even experiencing negative growth in 2023 [38]. Group 3: Market Position and Future Outlook - Despite being the market leader in cheese, Miaokelan Duo faces intense competition from rivals like Yili and Bright Dairy, which poses risks to its market share [38]. - Analysts express cautious optimism about the company's future under new management, suggesting that there is still significant potential for growth in China's cheese market [22][46]. - The transition to a new management team may help stabilize the company and enhance compliance, potentially leading to improved performance in the long term [46].
百菲乳业IPO终止!2024年净利润3亿,超过90%的生鲜乳依靠外购
梧桐树下V· 2026-01-31 03:34
Core Viewpoint - The IPO application of Guangxi Baifei Dairy Co., Ltd. has been terminated due to the withdrawal of the application by the company and its sponsor, Guorong Securities [1] Company Overview - The company was established in December 2017 and transformed into a joint-stock company in December 2019. It was listed on the New Third Board on June 28, 2024, with a registered capital of 165.502 million yuan. The controlling shareholder, Guangxi Baifei Investment Co., Ltd., holds 87.97% of the shares, with Wu Shouyun as the chairman and general manager [2] - The company operates 22 subsidiaries, one associate company, and three branches, employing 1,062 people as of the end of 2024 [2] Industry Position - The company is recognized as a key leading enterprise in agricultural industrialization, primarily engaged in the research, production, and sales of dairy products and milk-containing beverages. Its product range includes sterilized milk, modified milk, fermented milk, pasteurized milk, and milk-containing beverages [3] - As of the end of 2023, there were 654 large-scale dairy enterprises in China, with the company’s total assets, revenue, and profit significantly exceeding the average of its peers, being 2.37 times, 2.94 times, and 6.94 times higher than the averages, respectively [3] Financial Performance - The company reported revenues of 780.80 million yuan, 1.075 billion yuan, and 1.422 billion yuan for the years 2022, 2023, and 2024, respectively. The net profit after deducting non-recurring gains and losses was 117.10 million yuan, 227.15 million yuan, and 299.65 million yuan for the same years [5] - In the first half of 2025, the company achieved a revenue of 721.78 million yuan, an increase of 11.82% year-on-year, but the net profit after deducting non-recurring gains and losses decreased by 15.70% [5][7] Supply Chain Dependency - Over 90% of the fresh milk used by the company is sourced externally, with the procurement amount accounting for more than 50% of the total raw material costs. In 2022, the company relied entirely on external sources for fresh milk [9] - The main suppliers of fresh milk in 2024 included Ningxia Xingyuanda and its affiliates, as well as the Qingtongxia City Youyi Dairy Cattle Breeding Cooperative [10] IPO Fundraising Plans - The company planned to raise 496.78 million yuan through its IPO, which was intended for the construction of a smart dairy farm, marketing network development, and brand promotion projects [14][16]
市场监管总局公布十起违法广告典型案例
Yang Shi Wang· 2026-01-31 03:16
Core Viewpoint - In 2025, the State Administration for Market Regulation (SAMR) conducted a nationwide campaign to rectify advertising market order, focusing on key livelihood areas such as healthcare, pharmaceuticals, medical devices, food, and children's myopia prevention, resulting in the investigation of 44,521 advertising violations and fines totaling 252 million yuan [1] Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for misleading advertisements claiming health benefits related to eye care products [2] - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for false claims regarding the health benefits of camel milk powder [2] - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising ceramic tableware as being from Jingdezhen [3] - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising organic perilla seed oil with unverified health claims [4] - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting various health products with exaggerated claims [5] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising eye care patches with unsubstantiated treatment claims [7] - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading real estate advertisements that included unapproved infrastructure claims [8] - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health products with false efficacy claims [9] - Songyuan Anorectal Hospital was fined 100,000 yuan for false advertising regarding its medical qualifications [10] - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for advertising prescription drugs in violation of regulations [10]